J-Lex

Gefitinib tablets 250mg “Sawai”

Gefitinib tablets 250mg “Sawai,” manufactured by Sawai Pharmaceutical (YJ code: 4291013F1060, standard: 250mg x 1 tablet), contain gefitinib, which works by blocking the action of an abnormal protein that causes the multiplication of cancerous cells in non-small cell lung cancer.

← Back to search

Need more detailed information?

Contact TASAKI PHARMA for inquiries about this medicine (English support available).

Contact us about this drug →

More with the same ingredient

More from this manufacturer